| 68Ga-FAPI PET/CT: tracer uptake in 28 different kinds of cancer C Kratochwil, P Flechsig, T Lindner, L Abderrahim, A Altmann, W Mier, ... Journal of Nuclear Medicine 60 (6), 801-805, 2019 | 995 | 2019 |
| 68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging M Eder, M Schäfer, U Bauder-Wüst, WE Hull, C Wängler, W Mier, ... Bioconjugate chemistry 23 (4), 688-697, 2012 | 966 | 2012 |
| The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis A Schneider, C Krüger, T Steigleder, D Weber, C Pitzer, R Laage, ... The Journal of clinical investigation 115 (8), 2083-2098, 2005 | 882 | 2005 |
| Phenolic compounds and squalene in olive oils: the concentration and antioxidant potential of total phenols, simple phenols, secoiridoids, lignansand squalene RW Owen, W Mier, A Giacosa, WE Hull, B Spiegelhalder, H Bartsch Food and Chemical Toxicology 38 (8), 647-659, 2000 | 809 | 2000 |
| Isolation, structure elucidation and antioxidant potential of the major phenolic and flavonoid compounds in brined olive drupes RW Owen, R Haubner, W Mier, A Giacosa, WE Hull, B Spiegelhalder, ... Food and chemical toxicology 41 (5), 703-717, 2003 | 774* | 2003 |
| PSMA-targeted radionuclide therapy of metastatic castration-resistant prostate cancer with 177Lu-labeled PSMA-617 C Kratochwil, FL Giesel, M Stefanova, M Benešová, M Bronzel, ... Journal of Nuclear Medicine 57 (8), 1170-1176, 2016 | 626 | 2016 |
| Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein T Lindner, A Loktev, A Altmann, F Giesel, C Kratochwil, J Debus, D Jäger, ... Journal of Nuclear Medicine 59 (9), 1415-1422, 2018 | 616 | 2018 |
| Preclinical evaluation of a tailor-made DOTA-conjugated PSMA inhibitor with optimized linker moiety for imaging and endoradiotherapy of prostate cancer M Benešová, M Schäfer, U Bauder-Wüst, A Afshar-Oromieh, C Kratochwil, ... Journal of Nuclear Medicine 56 (6), 914-920, 2015 | 596 | 2015 |
| F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients FL Giesel, B Hadaschik, J Cardinale, J Radtke, M Vinsensia, W Lehnert, ... European journal of nuclear medicine and molecular imaging 44, 678-688, 2017 | 556 | 2017 |
| Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy A Bierhaus, T Fleming, S Stoyanov, A Leffler, A Babes, C Neacsu, ... Nature medicine 18 (6), 926-933, 2012 | 547 | 2012 |
| Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients A Afshar-Oromieh, T Holland-Letz, FL Giesel, C Kratochwil, W Mier, ... European journal of nuclear medicine and molecular imaging 44, 1258-1268, 2017 | 535 | 2017 |
| 68Ga-FAPI PET/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers FL Giesel, C Kratochwil, T Lindner, MM Marschalek, A Loktev, W Lehnert, ... Journal of Nuclear Medicine 60 (3), 386-392, 2019 | 512 | 2019 |
| A tumor-imaging method targeting cancer-associated fibroblasts A Loktev, T Lindner, W Mier, J Debus, A Altmann, D Jäger, F Giesel, ... Journal of Nuclear Medicine 59 (9), 1423-1429, 2018 | 512 | 2018 |
| Betulinic acid triggers CD95 (APO-1/Fas)-and p53-independent apoptosis via activation of caspases in neuroectodermal tumors S Fulda, C Friesen, M Los, C Scaffidi, W Mier, M Benedict, G Nuñez, ... Cancer research 57 (21), 4956-4964, 1997 | 491 | 1997 |
| Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein J Petersen, M Dandri, W Mier, M Lütgehetmann, T Volz, F Von Weizsäcker, ... Nature biotechnology 26 (3), 335-341, 2008 | 448 | 2008 |
| The theranostic PSMA ligand PSMA-617 in the diagnosis of prostate cancer by PET/CT: biodistribution in humans, radiation dosimetry, and first evaluation of tumor lesions A Afshar-Oromieh, H Hetzheim, C Kratochwil, M Benesova, M Eder, ... Journal of Nuclear Medicine 56 (11), 1697-1705, 2015 | 423 | 2015 |
| Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy CM Zechmann, A Afshar-Oromieh, T Armor, JB Stubbs, W Mier, ... European journal of nuclear medicine and molecular imaging 41, 1280-1292, 2014 | 421 | 2014 |
| 213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience C Kratochwil, FL Giesel, F Bruchertseifer, W Mier, C Apostolidis, R Boll, ... European journal of nuclear medicine and molecular imaging 41, 2106-2119, 2014 | 397 | 2014 |
| Development of fibroblast activation protein–targeted radiotracers with improved tumor retention A Loktev, T Lindner, EM Burger, A Altmann, F Giesel, C Kratochwil, ... Journal of Nuclear Medicine 60 (10), 1421-1429, 2019 | 314 | 2019 |
| Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor S Nkongolo, Y Ni, FA Lempp, C Kaufman, T Lindner, K Esser-Nobis, ... Journal of hepatology 60 (4), 723-731, 2014 | 282 | 2014 |
